Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson's Disease Diagnosis and Duration

Overview

Journal J Parkinsons Dis

Publisher Sage Publications

Specialty Neurology

Date 2024 Apr 26

PMID 38669557

Authors

Eva Schaeffer

Annika Kluge

Claudia Schulte

Christian Deuschle

Josina Bunk

Julius Welzel

Walter Maetzler

Daniela Berg

Affiliations

Soon will be listed here.

Abstract

Background: Misfolded α-synuclein can be detected in blood samples of Parkinson's disease (PD) patients by a seed amplification assay (SAA), but the association with disease duration is not clear, yet.

Objective: In the present study we aimed to elucidate whether seeding activity of misfolded α-synuclein derived from neuronal exosomes in blood is associated with PD diagnosis and disease duration.

Methods: Cross-sectional samples of PD patients were analyzed and compared to samples of age- and gender-matched healthy controls using a blood-based SAA. Presence of α-synuclein seeding activity and differences in seeding parameters, including fluorescence response (in arbitrary units) at the end of the amplification assay (F60) were analyzed. Additionally, available PD samples collected longitudinally over 5-9 years were included.

Results: In the cross-sectional dataset, 79 of 80 PD patients (mean age 69 years, SD = 8; 56% male) and none of the healthy controls (n = 20, mean age 70 years, SD = 10; 55% male) showed seeding activity (sensitivity 98.8%). When comparing subgroups divided by disease duration, longer disease duration was associated with lower α-synuclein seeding activity (F60: p < 0.001). In the longitudinal analysis 10/11 patients showed a gradual decrease of α-synuclein seeding activity over time.

Conclusions: This study confirms the high sensitivity of the blood-based α-synuclein SAA applied here. The negative association of α-synuclein seeding activity in blood with disease duration makes this parameter potentially interesting as biomarker for future studies on the pathophysiology of disease progression in PD, and for biologically oriented trials in this field.

Citing Articles

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.

Kuang Y, Mao H, Huang X, Chen M, Dai W, Gan T Transl Neurodegener. 2024; 13(1):56.

PMID: 39574205 PMC: 11580393. DOI: 10.1186/s40035-024-00449-2.

A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson's disease.

Wang Z, Gilliland T, Kim H, Gerasimenko M, Sajewski K, Camacho M Acta Neuropathol Commun. 2024; 12(1):167.

PMID: 39439002 PMC: 11495072. DOI: 10.1186/s40478-024-01873-1.

Emerging Role of Extracellular Vesicles as Biomarkers in Neurodegenerative Diseases and Their Clinical and Therapeutic Potential in Central Nervous System Pathologies.

Malaguarnera M, Cabrera-Pastor A Int J Mol Sci. 2024; 25(18).

PMID: 39337560 PMC: 11432603. DOI: 10.3390/ijms251810068.

Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson's Disease.

Pilotto A, Zanusso G, Antelmi E, Okuzumi A, Zatti C, Lupini A J Parkinsons Dis. 2024; 14(s2):S333-S344.

PMID: 39331105 PMC: 11494635. DOI: 10.3233/JPD-240007.

References

Lin C, Li C, Yang K, Lin F, Wu C, Chieh J . Blood NfL: A biomarker for disease severity and progression in Parkinson disease. Neurology. 2019; 93(11):e1104-e1111. DOI: 10.1212/WNL.0000000000008088. View

Hentz J, Mehta S, Shill H, Driver-Dunckley E, Beach T, Adler C . Simplified conversion method for unified Parkinson's disease rating scale motor examinations. Mov Disord. 2016; 30(14):1967-70. PMC: 4717915. DOI: 10.1002/mds.26435. View

Siderowf A, Concha-Marambio L, Lafontant D, Farris C, Ma Y, Urenia P . Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023; 22(5):407-417. PMC: 10627170. DOI: 10.1016/S1474-4422(23)00109-6. View

Donadio V, Wang Z, Incensi A, Rizzo G, Fileccia E, Vacchiano V . In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC. Neurology. 2021; 96(20):e2513-e2524. PMC: 8205473. DOI: 10.1212/WNL.0000000000011935. View

Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View

Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H . Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression. Mov Disord. 2020; 35(11):1999-2008. PMC: 8017468. DOI: 10.1002/mds.28206. View

Fairfoul G, McGuire L, Pal S, Ironside J, Neumann J, Christie S . Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol. 2016; 3(10):812-818. PMC: 5048391. DOI: 10.1002/acn3.338. View

Compta Y, Painous C, Soto M, Pulido-Salgado M, Fernandez M, Camara A . Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again. Parkinsonism Relat Disord. 2022; 99:33-41. DOI: 10.1016/j.parkreldis.2022.05.006. View

Fasnacht J, Wueest A, Berres M, Thomann A, Krumm S, Gutbrod K . Conversion between the Montreal Cognitive Assessment and the Mini-Mental Status Examination. J Am Geriatr Soc. 2022; 71(3):869-879. DOI: 10.1111/jgs.18124. View

10.

Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orru C . Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020; 140(1):49-62. PMC: 7299922. DOI: 10.1007/s00401-020-02160-8. View

11.

Vivacqua G, Mason M, De Bartolo M, Wegrzynowicz M, Calo L, Belvisi D . Salivary α-Synuclein RT-QuIC Correlates with Disease Severity in de novo Parkinson's Disease. Mov Disord. 2022; 38(1):153-155. PMC: 10092811. DOI: 10.1002/mds.29246. View

12.

Stefani A, Iranzo A, Holzknecht E, Perra D, Bongianni M, Gaig C . Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain. 2021; 144(4):1118-1126. DOI: 10.1093/brain/awab005. View

13.

Kuzkina A, Panzer C, Seger A, Schmitt D, Rossle J, Schreglmann S . Dermal Real-Time Quaking-Induced Conversion Is a Sensitive Marker to Confirm Isolated Rapid Eye Movement Sleep Behavior Disorder as an Early α-Synucleinopathy. Mov Disord. 2023; 38(6):1077-1082. DOI: 10.1002/mds.29340. View

14.

Orru C, Ma T, Hughson A, Groveman B, Srivastava A, Galasko D . A rapid α-synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy. Ann Clin Transl Neurol. 2020; 8(2):374-384. PMC: 7886040. DOI: 10.1002/acn3.51280. View

15.

Hall S, Orru C, Serrano G, Galasko D, Hughson A, Groveman B . Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol Commun. 2022; 10(1):90. PMC: 9219141. DOI: 10.1186/s40478-022-01388-7. View

16.

Martinez-Valbuena I, Visanji N, Olszewska D, Sousa M, Bhakta P, Vasilevskaya A . Combining Skin α-Synuclein Real-Time Quaking-Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's Disease. Mov Disord. 2022; 37(3):648-650. DOI: 10.1002/mds.28912. View

17.

Pilotto A, Imarisio A, Conforti F, Scalvini A, Masciocchi S, Nocivelli S . Plasma NfL, clinical subtypes and motor progression in Parkinson's disease. Parkinsonism Relat Disord. 2021; 87:41-47. DOI: 10.1016/j.parkreldis.2021.04.016. View

18.

Wang Z, Becker K, Donadio V, Siedlak S, Yuan J, Rezaee M . Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol. 2020; . PMC: 7522783. DOI: 10.1001/jamaneurol.2020.3311. View

19.

Rodstrom E, Mattsson-Carlgren N, Janelidze S, Hansson O, Puschmann A . Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical Subtypes. J Parkinsons Dis. 2021; 12(2):571-584. PMC: 8925110. DOI: 10.3233/JPD-212866. View

20.

Kuzkina A, Bargar C, Schmitt D, Rossle J, Wang W, Schubert A . Diagnostic value of skin RT-QuIC in Parkinson's disease: a two-laboratory study. NPJ Parkinsons Dis. 2021; 7(1):99. PMC: 8593128. DOI: 10.1038/s41531-021-00242-2. View